BOLT

NASD Bolt Biotherapeutics, Inc.
Oct 31, 2026 · 1:17 PM ET EOD Market Closed

$6.59 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.59, and at the day’s high of $6.59

YTD change
+20.52%
vs 20-day SMA
+44.18%
vs 200-day SMA
+46.22%

Price ranges

Previous day
$6.09 $6.59
open $6.30 close $6.59
+$0.29 (+4.60%)
Today
$6.09 $6.59
$6.59
Past week
$4.19 $7.78
from $4.19 now $6.59
+$2.40 (+57.28%)
Past month
$3.38 $7.78
from $3.51 now $6.59
+$3.08 (+87.75%)
This year
$3.10 $7.78
from $5.47 now $6.59
+$1.12 (+20.52%)

Price & Performance

+1.53 (+30.24%) / 6M

$2.90$4.22$5.54$6.86May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 84.7% away from all-time highs of $43.07
  • BOLT is up 21% since the beginning of the year
  • BOLT is up 15% over the past 12 months
  • BOLT is up 88% over the past 1 month
  • 2% of all BOLT investors are betting against BOLT

BOLT reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +14.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-4.57
Earnings momentum -24.0% Quarterly EPS growth
Quarterly change -24.0%

Valuation

P/E ratio N/A
Enterprise value $14.6M
Beta 1.51

Balance sheet & scale

IncomeN/A
Revenue$4.7M
Cash$17.8M
Debt$21.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $12.7M

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $35.39 +1.11%
ARGX argenx SE Sponsored ADR $892.87 -0.55%
ONC BeOne Medicines Ltd. Sponsored ADR $370.33 -0.33%
INCY Incyte Corporation $120.39 +3.07%
WXIBF Wuxi Biologics (Cayman) Inc. $5.69 -3.64%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.